Identification of KIT-activating mutations as a key factor in the pathogenesis of GIST has substantially altered the diagnosis and treatment of GIST (Hirota et al, 1998; Corless et al, 2004; Miettinen and Lasota, 2006). Here, KIT is linked to gastrointestinal stromal tumor.